Antón Ussi

448 total citations
14 papers, 134 citations indexed

About

Antón Ussi is a scholar working on Molecular Biology, Public Health, Environmental and Occupational Health and Oncology. According to data from OpenAlex, Antón Ussi has authored 14 papers receiving a total of 134 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Public Health, Environmental and Occupational Health and 4 papers in Oncology. Recurrent topics in Antón Ussi's work include CAR-T cell therapy research (4 papers), Health and Medical Research Impacts (4 papers) and Biosimilars and Bioanalytical Methods (3 papers). Antón Ussi is often cited by papers focused on CAR-T cell therapy research (4 papers), Health and Medical Research Impacts (4 papers) and Biosimilars and Bioanalytical Methods (3 papers). Antón Ussi collaborates with scholars based in Netherlands, Czechia and Finland. Antón Ussi's co-authors include Giovanni Migliaccio, Marián Hajdúch, Florence Biétrix, Antoni L. Andreu, Andreas Scherer, Alain J. van Gool, Kurt Zatloukal, Andy Smith, Niklas Blomberg and Jan‐Eric Litton and has published in prestigious journals such as PLoS ONE, Nature Reviews Drug Discovery and Clinical Infectious Diseases.

In The Last Decade

Antón Ussi

12 papers receiving 131 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Antón Ussi Netherlands 7 49 22 21 17 17 14 134
Mary Beth Nierengarten United States 7 53 1.1× 10 0.5× 13 0.6× 59 3.5× 13 0.8× 80 202
Kirti Chauhan India 8 49 1.0× 9 0.4× 18 0.9× 9 0.5× 10 0.6× 21 144
Martina Loibner Austria 9 63 1.3× 33 1.5× 46 2.2× 55 3.2× 20 1.2× 18 308
Mamta Verma India 8 72 1.5× 20 0.9× 15 0.7× 21 1.2× 3 0.2× 15 176
Haliton Alves de Oliveira Brazil 8 23 0.5× 22 1.0× 16 0.8× 6 0.4× 3 0.2× 33 225
Gabrielle Bertier France 6 36 0.7× 16 0.7× 41 2.0× 10 0.6× 3 0.2× 14 169
Charles Mathews United States 7 52 1.1× 32 1.5× 38 1.8× 37 2.2× 6 0.4× 10 306
Allen F. Shih United States 5 89 1.8× 15 0.7× 31 1.5× 29 1.7× 13 0.8× 17 225
Jonathan G. Williams Australia 10 52 1.1× 15 0.7× 27 1.3× 10 0.6× 11 0.6× 29 297
Bernhard Irrgang Germany 5 64 1.3× 20 0.9× 15 0.7× 25 1.5× 4 0.2× 38 213

Countries citing papers authored by Antón Ussi

Since Specialization
Citations

This map shows the geographic impact of Antón Ussi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antón Ussi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antón Ussi more than expected).

Fields of papers citing papers by Antón Ussi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antón Ussi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antón Ussi. The network helps show where Antón Ussi may publish in the future.

Co-authorship network of co-authors of Antón Ussi

This figure shows the co-authorship network connecting the top 25 collaborators of Antón Ussi. A scholar is included among the top collaborators of Antón Ussi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antón Ussi. Antón Ussi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Corriol‐Rohou, Solange, Marta del Álamo, Mathieu Boudes, et al.. (2024). The Rare Disease Moonshot: Paradigms Shift, Translational Medicine, and Regulatory Science for the World's Rarest Conditions. Clinical Pharmacology & Therapeutics. 116(6). 1387–1390.
2.
Oldoni, Emanuela, Antón Ussi, Antoni L. Andreu, & David A. Morrow. (2023). It is time we got more personal with advanced therapies- How do we create the right ecosystem for more effective ATMP development in Europe?. Medical Research Archives. 11(9).
3.
Oldoni, Emanuela, Gary Saunders, Florence Biétrix, et al.. (2022). Tackling the translational challenges of multi-omics research in the realm of European personalised medicine: A workshop report. Frontiers in Molecular Biosciences. 9. 974799–974799. 12 indexed citations
4.
Oldoni, Emanuela, Chiara Gerardi, Rita Banzi, et al.. (2022). Evaluating Translational Methods for Personalized Medicine—A Scoping Review. Journal of Personalized Medicine. 12(7). 1177–1177. 6 indexed citations
5.
Seguí, Francesc López, Sandra Walsh, Antón Ussi, et al.. (2021). Clinical characteristics of COVID-19 in older adults. A retrospective study in long-term nursing homes in Catalonia. PLoS ONE. 16(7). e0255141–e0255141. 21 indexed citations
6.
Cash‐Gibson, Lucinda, Juan M. Pericàs, Eva Molero, et al.. (2021). EU-PEARL: Changing the paradigm of clinical trials in Europe. European Journal of Public Health. 31(Supplement_3). 4 indexed citations
7.
Andreu, Antoni L., et al.. (2020). EATRIS, the European Research Infrastructure for Translational Medicine and A_IATRIS, its Italian node. The International Journal of Biological Markers. 35(1_suppl). 3–4. 1 indexed citations
8.
Oldoni, Emanuela, Alain J. van Gool, Laura García‐Bermejo, et al.. (2020). Biomarker Research and Development for Coronavirus Disease 2019 (COVID-19): European Medical Research Infrastructures Call for Global Coordination. Clinical Infectious Diseases. 72(10). 1838–1842. 3 indexed citations
9.
Morrow, D. John, et al.. (2019). Broadly-applicable imaging platforms are necessary for optimizing cell therapies in solid tumors. Cell and Gene Therapy Insights. 5(7). 629–638. 1 indexed citations
10.
Ussi, Antón, et al.. (2017). Addressing Pressing Needs in the Development of Advanced Therapies. Frontiers in Bioengineering and Biotechnology. 5. 55–55. 21 indexed citations
11.
Gool, Alain J. van, Florence Biétrix, Eric Caldenhoven, et al.. (2017). Bridging the translational innovation gap through good biomarker practice. Nature Reviews Drug Discovery. 16(9). 587–588. 43 indexed citations
12.
Ussi, Antón, Martin de Kort, Nathan P. Coussens, Tero Aittokallio, & Marián Hajdúch. (2017). In Search of System‐Wide Productivity Gains ‐ The Role of Global Collaborations in Preclinical Translation. Clinical and Translational Science. 10(6). 423–425. 2 indexed citations
13.
Kočiš, Petr, Marián Hajdúch, Florence Biétrix, et al.. (2016). Putting translational science on to a global stage. Nature Reviews Drug Discovery. 15(4). 217–218. 12 indexed citations
14.
Dongen, Guus AMS van, et al.. (2013). EATRIS, a European initiative to boost translational biomedical research.. PubMed. 3(2). 166–74. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026